Fleury (FLRY3.SA) Akcija Kursas
Fleury Kursas
Per pastaruosius 19 metus Fleury pajamos augo 16,1 % kasmet ir pasiekė 8,29 mlrd. BRL. Pelnas akcijai augo 16,8 % per metus per pastaruosius 19 metus. Fleury grynoji marža 7,4 % yra sumažėjo palyginti su 9,0 % prieš kelerius metus. Esama kaina dividendo pajamingumas yra apie 8,06 %. Išmokų koeficientas yra apie 149 % pelno. Dividendas augo 20,5 % per metus per pastaruosius 15 metus. Fleury 12 mėn. konsensuso tikslinė kaina yra 18,36 BRL, apie žemiau kursą 11,7 %. Iš 19 analitikų 11 rekomenduoja pirkti — bendras konsensusas yra Pirkti.
Fleury akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Fleury akcija ir akcijų analizė
Dažnai užduodami klausimai apie Fleury akciją
The business model of Fleury SA, a leading medical diagnostics company in Brazil, revolves around providing high-quality healthcare services through its network of diagnostic imaging, clinical analysis, and other medical services. Fleury SA aims to ensure accurate diagnoses, offer timely access to medical procedures, and deliver exceptional customer experience. By investing in advanced technology, top-notch professionals, and continuous innovation, Fleury SA effectively meets the healthcare needs of patients across the country. With its strong reputation and diverse range of diagnostic services, Fleury SA strives to maintain its position as a market leader in Brazil's healthcare industry.
Fleury SA is primarily active in the healthcare industry.
The main competitors of Fleury SA in the market include Grupo Fleury, DASA, and Hermes Pardini.
Fleury SA is a leading healthcare company based in Brazil. With a rich history dating back to 1926, Fleury has continually evolved and expanded its operations to become one of the most reputable diagnostic medicine providers in the country. Over the years, the company has developed a strong reputation for its advanced diagnostic techniques and high-quality services, encompassing radiology, pathology, and clinical analysis. With a strong focus on technological innovation, Fleury has consistently invested in cutting-edge equipment and research, enabling them to deliver accurate and reliable results to patients. Today, Fleury SA stands as a trusted name in the healthcare industry, providing comprehensive diagnostic solutions to improve patient outcomes.
Fleury SA, a renowned company, has achieved remarkable milestones throughout its history. Having established a strong presence in the healthcare sector, Fleury SA continuously strives for excellence. Some significant achievements include expanding its network and becoming one of the largest healthcare providers in Brazil. Additionally, Fleury SA has consistently prioritized innovation, implementing advanced technology and processes to deliver high-quality diagnostics and medical solutions. The company's commitment to patient-centric care and a strong focus on research & development have further solidified its position as a trusted leader in the industry. Fleury SA's relentless pursuit of growth and unwavering dedication to improving healthcare services have contributed to its notable achievements.
Fleury SA is primarily present in Brazil, where it operates a wide network of diagnostic medicine and healthcare facilities. With its headquarters in São Paulo, the company is a leader in medical laboratory services, operating in several states across the country. Fleury SA's commitment to providing high-quality diagnostic services has allowed it to expand its presence to other regions of Brazil, catering to a diverse range of patients and medical professionals.
Fleury SA represents a strong set of values and corporate philosophy. With a focus on excellence and innovation, the company strives to deliver the highest quality healthcare services to patients. Fleury SA is committed to providing accurate diagnoses, personalized care, and cutting-edge medical technology. Through continuous improvement, the company aims to surpass industry standards and meet the evolving needs of its customers. With a reputation for professionalism and integrity, Fleury SA upholds a patient-centric approach, putting the well-being and satisfaction of individuals at the forefront. By encompassing these values, Fleury SA remains a trusted leader in the healthcare industry.
Analitikai šiuo metu nustato vidutinę Fleury akcijos tikslinę kainą 17,77 BRL (mediana: 18,36 BRL), t. y. −14,4 % palyginti su paskutine kaina. Konsensusas pagrįstas 19 analitikų reitingais.
18 analitikai šiuo metu vertina Fleury akciją: 11 rekomenduoja pirkti, 5 laikyti ir 2 parduoti. 2026 m. analitikai tikisi, kad Fleury gaus 9,29 mlrd. BRL pajamų ir 1,48 BRL pelno akcijai.
Pagal dabartinį kursą Fleury akcija kainuoja 3,27 EUR (20,79 BRL).
Fleury akcija (FLRY3.SA) kotiruojama 2 biržose, įskaitant: B3 (São Paulo) (FLRY3.SA).
Fleury SA is a company specializing in medical diagnostics and health services. Founded in 1926, the company is headquartered in Sao Paulo, Brazil. With over 9,000 employees and a revenue of more than 2.2 billion Brazilian Reals, Fleury SA is one of the largest medical service companies in South America. The business model of Fleury SA is based on three core areas: diagnostics, health services, and research and development. In diagnostics, the company enables disease identification and offers comprehensive diagnostic solutions. The portfolio of diagnostic services is very broad and includes imaging and radiological diagnostics, laboratory and pathology services, genetic testing, and screening for pregnancy-related diseases. In the field of health services, Fleury SA offers a wide range of services for individuals and companies looking to improve prevention, wellness, and quality of life. The services range from health counseling and health programs to outpatient surgery and rehabilitation facilities. In research and development, the company is interested in driving innovation in the fields of medical diagnostics and health services. Fleury SA invests heavily in the development of new technologies and solutions to improve the accuracy and efficiency of its diagnostic services, as well as in collaboration with academic institutions and other companies. The company is known for adhering to very high quality standards in all aspects of its services. Fleury SA is ISO 9001 certified and is committed to continuously working towards customer satisfaction and process optimization. The company is proud to offer state-of-the-art technology and top-notch medical professionals to provide customers with the best possible service. In addition to its business areas, Fleury SA also offers a variety of products, such as diagnostic instruments and consumables for medical professionals, medical software, and health products for the general public. The products are designed to meet the needs of medical professionals and private consumers and meet the highest quality standards. Overall, Fleury SA has an impressive track record in the field of medical diagnostics and health services. The company has established itself as a trusted provider of high-quality and innovative solutions over the past decades and is committed to continuing to lead the industry with excellence and groundbreaking innovations.
tikėtina pelnas Fleury yra 9,29 mlrd. BRL. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Fleury yra 803,99 mln. BRL. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Fleury šiuo metu yra 14,09. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Fleury akcijos vertę.
Kainų ir pardavimų santykis (KUV) Fleury šiuo metu yra 1,22. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Fleury akcijos įvertinimo metrika.
Eulerpool kokybės balas Fleury yra 7/10.
Fleury ISIN yra BRFLRYACNOR5. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Fleury prekybos žymė yra FLRY3.SA. Ši biržos žymė naudojama Fleury akcijoms prekiauti biržoje.
Fleury akcija
Fleury Pagrindiniai konkurentai
Fleury Biržos simbolis
Fleury FIGI
Visos Fleury pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Fleury akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Fleury. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: